𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recursive partitioning for prognostic grouping of patients with clinically localized prostate carcinoma

✍ Scribed by Mousumi Banerjee; Debjit Biswas; Wael Sakr; David P. Wood Jr.


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
117 KB
Volume
89
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


An enhanced prognostic system for clinic
✍ Thomas M. Pisansky; Michael J. Kahn; David G. Bostwick πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 121 KB πŸ‘ 1 views

## Background: This investigation was conducted to develop an enhanced prognostic system based on readily available and independently predictive tumor-related factors for patients with clinically localized prostate carcinoma. ## Methods: The outcome of 500 patients treated solely with irradiation

Prognostic factors for clinically locali
✍ Gunar K. Zagars; Alan Pollack; Andrew C. von Eschenbach πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 212 KB πŸ‘ 1 views

The Uniirradiated in the PSA era. versity of Texas, M. D. Anderson Cancer Center, ## METHODS. The authors analyzed the outcome for a group of 938 men with T1-T4,

A multiple prognostic index predictive o
✍ Thomas M. Pisansky; Michael J. Kahn; Gregory M. Rasp; Stephen S. Cha; Michael G. πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 113 KB πŸ‘ 1 views

## Background: This investigation was conducted to identify independent pretherapy disease-related factors associated with disease outcome in patients with clinically localized carcinoma of the prostate (cap) and to develop models that incorporated relevant covariates for estimating the risk of dis

Comparative immunocytochemical assessmen
✍ Jens KΓΆllermann,; Bernarda Heseding; Burkhard Helpap; Manfred W. KΓΆllermann; Kla πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 87 KB πŸ‘ 1 views

After radical prostatectomy for clinically localized prostate cancer, biochemical progression is seen in up to 40% of the patients due to persistent local and/or systemic remnants. Isolated disseminated carcinoma cells, undetectable by current staging methods, are of special interest as potential pr